They don’t have it ie the spare capital.
Full derisk by sizeable raise now before it’s too late. I don’t think $20m is enough at this point to cater for payables and expansion underground. Forget stage 3, if they even do it, will require $50m + for development and, more importantly, modifications to processing to creat a concentrate. Stage 3 is a pipe dream and the returns will not justify the capital.
$40m at 10 - 12c
Then they may have a chance to trade out of it.
Financiers will want nothing to do with this so equity it is and they will need to make it very attractive given circumstances.
- Forums
- ASX - By Stock
- CAI
- Ann: Half Year Accounts
Ann: Half Year Accounts, page-31
Featured News
Add CAI (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.67M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CAI (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online